SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-017651
Filing Date
2023-02-09
Accepted
2023-02-09 17:00:26
Documents
2
Group Members
INSPIRATIONAL VISIONS B.V.PATRICK JOHAN HENDRIK KROLPRIVIUM FUND MANAGEMENT B.V.STICHTING AESCAP GENETICS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm235875d1_sc13ga.htm SC 13G/A 84656
2 EXHIBIT 99.1 tm235875d1_ex99-1.htm EX-99.1 7803
  Complete submission text file 0001104659-23-017651.txt   94233
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Subject) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88671 | Film No.: 23607138
SIC: 2834 Pharmaceutical Preparations

Mailing Address GUSTAV MAHLERPLEIN 3 AMSTERDAM P7 1082 MS
Business Address GUSTAV MAHLERPLEIN 3 AMSTERDAM P7 1082 MS 31 20 462 6644
Stichting Aescap Life Sciences (Filed by) CIK: 0001771821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A